8-K: Veeco Supplements Merger Proxy Amid Shareholder Lawsuits

Veeco Instruments Inc. has voluntarily supplemented its definitive proxy statement for the Axcelis merger following shareholder lawsuits challenging disclosure adequacy, aiming to avoid litigation delays.

Summary

• Veeco Instruments Inc. is proceeding with its merger with Axcelis Technologies, Inc., with a special stockholder meeting scheduled for February 6, 2026, at 10:00 a.m. Eastern Time.
• The company has received 15 demand letters and 3 complaints from purported stockholders challenging the adequacy of disclosures in the merger proxy statements.
• The lawsuits, including Turner v. Veeco Instruments Inc. et al., Clark v. Veeco Instruments Inc. et al., and Garfield v. Bayless et al., allege negligence, negligent misrepresentation, failure to disclose, and breach of fiduciary duties.
• Plaintiffs seek to enjoin the merger or rescission if consummated, with a preliminary injunction motion filed in the Garfield Action on January 25, 2026.
• Veeco and Axcelis deny the allegations and believe the proxy statement is compliant, but Veeco is voluntarily supplementing disclosures to avoid litigation burden, expense, and potential merger delays.
• Supplemental disclosures include details on director recusals, the formation and role of the Veeco Strategic Planning Committee, and specifics of the merger negotiation process, including exchange ratio proposals and governance discussions.
• Financial analyses from J.P. Morgan (Axcelis's advisor) and UBS (Veeco's advisor) are further detailed, including discounted cash flow assumptions, public company comparisons, and implied equity values.
• UBS's analysis indicated an implied equity value per share for Veeco common stock of $30.14 to $36.54 on a standalone basis, and $32.91 to $40.07 for the combined company (including cost synergies).
• Details on executive and director equity awards and potential 280G mitigation actions are also supplemented.

Sentiment

Score: 6

Explanation: The filing addresses legal challenges to a significant merger, which introduces uncertainty and potential delays. However, management's proactive steps to supplement disclosures and the financial analysis indicating value creation from the merger provide a degree of confidence in the transaction's eventual completion and benefits. The ongoing litigation and the need for voluntary disclosures temper an otherwise positive outlook on the merger itself.

Positives

• The combined company analysis by UBS indicated a higher implied equity value per share for Veeco common stock ($32.91 to $40.07) compared to Veeco on a standalone basis ($30.14 to $36.54), suggesting potential value creation from the merger.
• Management is taking proactive steps to address shareholder concerns by voluntarily supplementing disclosures, aiming to avoid litigation and potential delays to the merger.
• The August 12 Axcelis Proposal represented an 18% premium to the average exchange ratio over the one-month period prior to its submission.
• The Veeco Strategic Planning Committee was formed as a committee of convenience to explore strategic alternatives, indicating a structured approach to evaluating the merger.

Negatives

• Multiple stockholder lawsuits and demand letters have been filed, alleging inadequate disclosures and breaches of fiduciary duties related to the merger.
• The lawsuits seek significant relief, including enjoining the merger or rescission, which could disrupt or prevent the transaction.
• A motion for a preliminary injunction was filed on January 25, 2026, seeking to halt the stockholder vote until the proxy statement is supplemented.
• The company is incurring the burden and expense of potential litigation, even while denying the merit of the allegations.

Risks

• Failure to obtain applicable regulatory or stockholder approvals in a timely manner or otherwise.
• Failure to satisfy other closing conditions to the proposed transaction or to complete it on anticipated terms and timing.
• Negative effects of the announcement of the proposed transaction.
• Risks that the businesses will not be integrated successfully or that the combined company will not realize expected benefits, cost savings, accretion, synergies, and/or growth, or that such benefits may take longer or be more costly to achieve.
• Disruptions from the proposed transaction harming business plans and operations.
• Risks relating to unanticipated costs of integration.
• Significant transaction and/or integration costs, or difficulties in connection with the proposed transaction and/or unknown or inestimable liabilities.
• Restrictions during the pendency of the proposed transaction that may impact the ability to pursue certain business opportunities or strategic transactions.
• Potential litigation associated with the proposed transaction (already ongoing).
• Potential impact of the announcement or consummation of the proposed transaction on Axcelis, Veeco's, or the combined company's relationships with suppliers, customers, employees, and regulators.
• Demand for the combined company's products.
• Economic, political, and social conditions in operating countries.
• Disruption to manufacturing facilities or operations due to natural catastrophic events, health epidemics, or terrorism.
• Ongoing changes in the technology and semiconductor industries, including growth rates, pricing trends, or customer capital spending patterns.
• Ability to timely develop new technologies and products.
• Ability to maintain technology advantage and protect proprietary rights.
• Ability to compete with new products from competitors.
• Ability of the company or its customers to obtain U.S. export control licenses for sales to customers in China.

Future Outlook

The filing reiterates forward-looking statements regarding future industry demand for semiconductors, regulatory landscape, market position, financial forecasts, investment plans, shareholder returns, and potential synergies from the Axcelis merger. It highlights the expectation of successful integration and realization of benefits, cost savings, accretion, synergies, and growth, while also acknowledging various risks that could cause actual results to differ materially.

Management Comments

• "Veeco and Axcelis believe that the allegations in the Stockholder Actions are without merit."
• "The Company denies that the Definitive Proxy Statement is deficient in any respect."
• "The Company denies that it has violated any laws or breached any duties to the Company's stockholders, denies all allegations in the Stockholder Actions, and believes no supplemental disclosure to the Definitive Proxy Statement was or is required under any applicable law, rule, or regulation."
• "However, solely to eliminate the burden and expense of potential litigation, and to avoid potential delay or disruption to the Merger, the Company has determined to voluntarily supplement the Definitive Proxy Statement with the below disclosures."
• "The Company believes that the disclosures set forth in the Definitive Proxy Statement comply fully with applicable law and nothing in the below supplemental disclosures will be deemed an admission of the legal necessity or materiality under applicable law of any of the disclosures set forth herein."

Industry Context

The merger between Veeco and Axcelis is positioned within the semiconductor capital equipment (SemiCap) industry. The supplemental disclosures include financial analyses that compare Veeco and Axcelis to a selection of mid-cap and large-cap SemiCap companies like ASM International, Nova Ltd., Onto Innovation Inc., ASML Holding N.V., Lam Research Corporation, and Applied Materials, Inc., indicating the companies operate within a competitive and dynamic sector driven by technological advancements and capital spending patterns. The merger aims to create a combined entity with potential for synergies and enhanced market position in this industry.

Comparison to Industry Standards

• UBS's Selected Public Companies Analysis compared Veeco and Axcelis to a group of Mid-Cap SemiCap companies (ASM International NV, Nova Ltd., Onto Innovation Inc., Camtek Ltd., FormFactor, Inc., AIXTRON SE) and Large-Cap SemiCap companies (ASML Holding N.V., Lam Research Corporation, Applied Materials, Inc., KLA Corporation, Tokyo Electron Limited) based on EV/2025E Adjusted EBITDA, EV/2026E Adjusted EBITDA, P/2025E Earnings, and P/2026E Earnings multiples.
• The analysis used these industry multiples, selected by UBS based on professional judgment and qualitative differences, to derive implied equity values for Veeco and Axcelis.
• J.P. Morgan's analysis also referenced publicly available equity research analysts' price targets for Veeco ($21.00 to $30.00 per share) and Axcelis ($81.00 to $90.00 per share), providing a market-based comparison.

Corporate Governance

Legal Proceedings

• Fifteen demand letters received by Veeco and Axcelis from purported stockholders challenging disclosure adequacy.
• Turner v. Veeco Instruments Inc. et al., Index No. 650266/2026 (N.Y. Sup. Ct. Jan. 14, 2026), filed in the Supreme Court of the State of New York, County of New York, alleging negligence and negligent misrepresentation against Veeco and its board of directors.
• Clark v. Veeco Instruments Inc. et al., Index No. 650284/2026 (N.Y. Sup. Ct. Jan. 15, 2026), filed in the Supreme Court of the State of New York, County of New York, alleging negligence and negligent misrepresentation against Veeco, its board of directors, and Axcelis.
• Garfield v. Bayless et al., Index No. 601340/2026 (N.Y. Sup. Ct. Jan. 20, 2026), filed in the Supreme Court of the State of New York, County of Nassau, alleging failure to disclose, breach of fiduciary duties, and aiding and abetting breach of fiduciary duties against Veeco, its board of directors, and Axcelis.
• All three complaints seek, among other relief, an order enjoining the Merger or rescission if the Merger is consummated.
• On January 25, 2026, the plaintiff in the Garfield Action filed a motion for a preliminary injunction, seeking to enjoin Veeco and its directors from closing the stockholder vote on the Merger until the Definitive Proxy is supplemented.

Related Party Transactions

• Thomas St. Dennis serves as an independent director on both the Axcelis board of directors and the Veeco board of directors, but recused himself from merger discussions and did not receive confidential information.
• Dr. Russell Low, the Chief Executive Officer of Axcelis, was previously employed at Veeco as Vice President of Engineering from 2012 to 2016.

Stakeholder Impact

• Shareholders: Potential for increased value from the merger as indicated by UBS's combined company analysis ($32.91 to $40.07 per share for Veeco stock vs. standalone $30.14 to $36.54). However, ongoing litigation introduces uncertainty and potential delays to the merger's completion. Veeco stockholders are expected to receive 40% ownership of the combined company.
• Executive Officers: Equity awards (RSUs, PSUs) will be assumed by Axcelis and converted, or in the case of Veeco Director RSAs, fully vested and canceled, receiving merger consideration. Potential for 280G mitigation actions (e.g., accelerated vesting) to reduce excise tax impact.
• Directors: Veeco Director RSAs will fully vest and be canceled, receiving merger consideration. Non-employee directors hold unvested restricted stock awards that will vest. Thomas St. Dennis's dual role and recusal are noted.
• Employees: Axcelis expected to enter into employment arrangements with key employees across the organization, though no such agreements were negotiated prior to the Merger Agreement. The merger could lead to integration efforts and potential changes in roles or organizational structure.
• Customers/Suppliers: The merger could impact relationships, as noted in the forward-looking statements, but the combined entity aims to strengthen its position in the semiconductor equipment sector.

Next Steps

• Veeco will hold a special meeting of its stockholders on February 6, 2026, at 10:00 a.m. Eastern Time, to vote on the merger.
• The company may take actions to mitigate the potential impact of Sections 280G and 4999 of the Code on executive officers' payments and benefits, which could include accelerating equity vesting in 2025.
• The merger is subject to the satisfaction or waiver of specified conditions.
• Integration of the businesses post-merger.

Key Dates

Recommendation

The filing provides crucial updates on the Veeco-Axcelis merger, including the ongoing shareholder lawsuits and the company's voluntary supplemental disclosures. While the financial analysis from UBS suggests potential value creation for Veeco shareholders in the combined entity, the legal challenges introduce a significant layer of uncertainty and risk of delay or even termination. The company's proactive stance to mitigate litigation is positive, but the outcome of the preliminary injunction motion and the broader lawsuits remains unknown. Given the potential upside from the merger but the immediate overhang of legal proceedings, a "hold" recommendation is appropriate. Investors should await further clarity on the legal front and the successful completion of the shareholder vote before making more aggressive moves.

Keywords

Merger, Acquisition, SEC Filing, 8-K, Veeco Instruments, Axcelis Technologies, Semiconductor Equipment, Stockholder Lawsuit, Proxy Statement, Corporate Governance, Financial Analysis, Valuation, Risk Factors, Integration, Shareholder Vote